Peptic ulcer bleeding: Interaction between non-steroidal anti- inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 11, 1999, Pages 1082-1086

  Kuyvenhoven, J Ph ^a   Veenendaal, R A ^a   Vandenbroucke, J P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ABO blood group system; Bleeding; Helicobacter pylori; Interaction; Non steroidal anti inflammatory drugs; Peptic ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ABO BLOOD-GROUP SYSTEM; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NETHERLANDS; ODDS RATIO; PEPTIC ULCER HEMORRHAGE; PREVALENCE; RISK FACTORS;

EID: 0032738082     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750024869     Document Type: Article

References (28)

1. 1. Graham DY. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol 1996;91:2080-6.
2. 2. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9 Suppl 2:59-69.
3. 3. Vaira D, Menegatti M, Miglioli M. What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology 1997;113:S78-84.
4. 4. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787-96.
5. 5. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
6. 6. Veldhuyzen van Zanten SJO. Commentary: bleeding ulcers, interaction between NSAIDs and Helicobacter pylori infection, and nonulcer dyspepsia. Gastroenterology 1997;113:S90-2.
7. 7. Hawkey CJ. Are NSAIDs and Helicobacter pylori separate risk factors? In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori: basic research to clinical cure 1996. London: Kluwer Academic; 1996. p. 312-23.
8. 8. Aird I, Bentall HH, Mehigan JA, Roberts JAF. The blood groups in relation to peptic ulceration and to carcinoma of colon, rectum, breast, and bronchus. Br Med J 1954;2:315-21.
9. 9. Berg M. Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers. Gut 1969;10:1029-30.
10. 10. Veenendaal RA, Gotz JM, Schroijen V, Kurban F, Bernards AT, Veselic M, et al. Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies. J Clin Pathol 1995;48:990-3.
11. 11 Nijenhuis LE. Blood group frequencies in the Netherlands, Curacao, Surinam and New Guinea. A study in population genetics [thesis]. Amsterdam: University of Amsterdam; 1961. p. 26-45.
12. 12. Loffeld RJLF, Stobberingh E, Spreeuwel JPv, Flendrig JA, Arends JW. Prevalence of anti-Helicobacter (campylobacter) pylori antibodies in patients and healthy blood donors. J Med Microbiol 1990;32:105-9.
13. 13. Veenendaal RA, Biemond I, Peña AS, van Duyn W, Kreuning J, Lamers CBHW. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 1992;33:452-5.
14. 14. Schlemper RJ, Werf SDJvd, Vandenbroucke JP, Biemond I, Lamers CBHW. Non-ulcer dyspepsia in a Dutch working population and Helicobacter pylori: ulcer history as an explanation of an apparant association. Arch Intern Med 1995; 155:82-7.
15. 15. Veenendaal RA, Biemond I, Ligthart GJ, Lamers CBHW. Helicobacter pylori and pepsinogens in the very old. In: Veenendaal RA, editor. Immunological and serodiagnostic aspects of Helicobacter pylori infection [thesis]. Leiden: Rijksuniversiteit Leiden; 1994. p. 127-38.
16. 16. Leufkens HG, Ameling CB, Hekster YA, Bakker A. Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population. Pharm Weekbl Sci 1990;12:97-103.
17. 17. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994;154:42-6.
18. 18. Guess HA, West R, Strand LM, Helston D, Lydick EG, Bergman U, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988;41:35-45.
19. 19. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perz-Perez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-6.
20. 20. Kosunen TU, Höök J, Rautelin HI, Myllylä G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989;24:110-4.
21. 21. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999;116:1305-9.
22. 22. Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. A case-control study. Dig Dis Sci 1997;42:586-91.
23. 23. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999;33:234-7.
24. 24. Henriksson AE, Edman A-C, Nilsson I, Bergqvist D, Wadström T. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. Scand J Gastroenterol 1998;33:1030-3.
25. 25. Cullen DJE, Hawkey GM, Greenwood DC, Humphreys H, Shephard V, Logan RFA, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997;41:459-62.
26. 26. Taha AS, Boothman P, Holland P, McKinlay A, Upashyay R, Kelly RW, et al. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol 1990;85:47-50.
27. 27. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748-51.
28. 28. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M, Weinstein WM. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Aliment Pharmacol Ther 1995;9:127-35.